K W Kastrup

1.8k total citations
47 papers, 1.4k citations indexed

About

K W Kastrup is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, K W Kastrup has authored 47 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 16 papers in Genetics and 9 papers in Molecular Biology. Recurrent topics in K W Kastrup's work include Growth Hormone and Insulin-like Growth Factors (24 papers), Sexual Differentiation and Disorders (7 papers) and Diabetes and associated disorders (6 papers). K W Kastrup is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (24 papers), Sexual Differentiation and Disorders (7 papers) and Diabetes and associated disorders (6 papers). K W Kastrup collaborates with scholars based in Denmark, United States and Switzerland. K W Kastrup's co-authors include Anders Juul, Niels E. Skakkebæk, B Zachau-Christiansen, Geir Joner, Jørn Nerup, K. Borch‐Johnsen, M. Christy, Thomas Mandrup‐Poulsen, Hans Ørskov and John Christiansen and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and PEDIATRICS.

In The Last Decade

K W Kastrup

46 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K W Kastrup Denmark 18 878 482 349 274 261 47 1.4k
F. De Luca Italy 25 924 1.1× 382 0.8× 463 1.3× 328 1.2× 259 1.0× 76 2.0k
Margaret H. MacGillivray United States 28 1.0k 1.1× 517 1.1× 531 1.5× 177 0.6× 324 1.2× 83 1.8k
B Boscherini Italy 23 779 0.9× 460 1.0× 659 1.9× 266 1.0× 193 0.7× 87 1.6k
Solomon A. Kaplan United States 28 1.1k 1.2× 330 0.7× 577 1.7× 410 1.5× 344 1.3× 79 2.3k
Dorothy I. Shulman United States 20 1.0k 1.1× 602 1.2× 472 1.4× 358 1.3× 232 0.9× 69 1.9k
Silvana Salardi Italy 27 923 1.1× 634 1.3× 438 1.3× 718 2.6× 269 1.0× 81 2.2k
Neville J. Howard Australia 26 1.2k 1.3× 910 1.9× 239 0.7× 660 2.4× 148 0.6× 47 2.0k
J.M. Wit Netherlands 18 469 0.5× 417 0.9× 377 1.1× 89 0.3× 357 1.4× 39 1.1k
Giorgio Radetti Italy 28 1.3k 1.5× 616 1.3× 525 1.5× 246 0.9× 314 1.2× 90 2.4k
Alessandro Salvatoni Italy 24 499 0.6× 789 1.6× 431 1.2× 570 2.1× 194 0.7× 72 1.7k

Countries citing papers authored by K W Kastrup

Since Specialization
Citations

This map shows the geographic impact of K W Kastrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K W Kastrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K W Kastrup more than expected).

Fields of papers citing papers by K W Kastrup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K W Kastrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K W Kastrup. The network helps show where K W Kastrup may publish in the future.

Co-authorship network of co-authors of K W Kastrup

This figure shows the co-authorship network connecting the top 25 collaborators of K W Kastrup. A scholar is included among the top collaborators of K W Kastrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K W Kastrup. K W Kastrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lange, Martin, Jørn Müller, Ole Lander Svendsen, et al.. (2004). The impact of idiopathic childhood‐onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD. Clinical Endocrinology. 62(1). 18–23. 6 indexed citations
2.
Jensen, B L, Kim Ebensgaard Jensen, K W Kastrup, Sidsel Arnspang Pedersen, & Arthur Wagner. (1998). Final height and craniofacial development after surgical resection of craniopharyngioma.. PubMed. 17(4). 190–7. 2 indexed citations
3.
4.
Juul, Anders, et al.. (1997). Growth Hormone (GH) Provocative Retesting of 108 Young Adults with Childhood-Onset GH Deficiency and the Diagnostic Value of Insulin-Like Growth Factor I (IGF-I) and IGF-Binding Protein-31. The Journal of Clinical Endocrinology & Metabolism. 82(4). 1195–1201. 118 indexed citations
5.
Juul, Anders, Kirsten Holm, K W Kastrup, et al.. (1997). Free Insulin-Like Growth Factor I Serum Levels in 1430 Healthy Children and Adults, and Its Diagnostic Value in Patients Suspected of Growth Hormone Deficiency1. The Journal of Clinical Endocrinology & Metabolism. 82(8). 2497–2502. 142 indexed citations
6.
Næraa, Rune Weis, Johannes Nielsen, & K W Kastrup. (1994). Growth hormone and 17β-oestradiol treatment of Turner girls — 2-year results. European Journal of Pediatrics. 153(2). 72–77. 18 indexed citations
7.
Grahnén, A., K W Kastrup, U. Heinrich, et al.. (1993). Pharmacokinetics of recombinant human insulin‐like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency. Acta Paediatrica. 82(s392). 9–13. 52 indexed citations
8.
Mortensen, Henrik B., Katharina M. Main, Kim F. Michaelsen, et al.. (1991). Predicting and Monitoring of Growth in Children with Short Stature during the First Year of Growth Hormone Treatment. Acta Paediatrica. 80(12). 1150–1157. 12 indexed citations
9.
Mortensen, Henrik B., Karin Marinelli, Kirsten Nørgaard, et al.. (1990). A Nation‐wide Cross‐sectional Study of Urinary Albumin Excretion Rate, Arterial Blood Pressure and Blood Glucose Control in Danish Children with Type 1 Diabetes Mellitus. Diabetic Medicine. 7(10). 887–897. 77 indexed citations
10.
Wandrup, J., John Kroner, Ole Pryds, & K W Kastrup. (1988). Age-related reference values for ionized calcium in the first week of life in premature and full-term neonates. Scandinavian Journal of Clinical and Laboratory Investigation. 48(3). 255–260. 13 indexed citations
11.
Christiansen, Peter Munk, Ove Hansen, N Hobolth, et al.. (1988). Treatment of Cryptorchidism with Human Chorionic Gonadotropin or Gonadotropin Releasing Hormone. Hormone Research. 30(4-5). 187–192. 35 indexed citations
12.
Kastrup, K W. (1988). Oestrogen Therapy in Turner's Syndrome. Acta Paediatrica. 77(s343). 43–46. 17 indexed citations
13.
Pryds, Ole, et al.. (1987). Circulating Autoantibodies to Thyroid Hormones: A Diagnostic Pitfall. Acta Paediatrica. 76(4). 685–687. 2 indexed citations
14.
Christiansen, John, K W Kastrup, K. G. M. M. Alberti, et al.. (1985). Higher plasma somatomedin A (biological) and C (immunological) levels with sc than with im growth hormone replacement therapy. European Journal of Endocrinology. 109(2). 169–172. 1 indexed citations
15.
Pedersen, P. S. & K W Kastrup. (1983). SOMATOMEDIN IN CYSTIC FIBROSIS. Acta Paediatrica. 72(5). 757–758. 6 indexed citations
16.
Kastrup, K W, et al.. (1983). Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient children. European Journal of Endocrinology. 104(2). 148–152. 115 indexed citations
17.
Kastrup, K W & Jürgen Zapf. (1979). NON-SUPPRESSIBLE INSULIN-LIKE ACTIVITY IN LARON'S SYNDROME. European Journal of Endocrinology. 90(3). 414–420. 3 indexed citations
18.
19.
Kastrup, K W, et al.. (1978). SOMATOMEDIN IN NEWBORNS AND THE RELATIONSHIP TO HUMAN CHORIONIC SOMATOTROPIN AND FETAL GROWTH. Acta Paediatrica. 67(6). 757–762. 16 indexed citations
20.
Kastrup, K W, et al.. (1971). Phenobarbital as Prophylaxis for Febrile Convulsions. Epilepsia. 12(1). 109–112. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by F. De Luca Breakdown of academic impact, for papers by Margaret H. MacGillivray Breakdown of academic impact, for papers by B Boscherini Breakdown of academic impact, for papers by Solomon A. Kaplan Breakdown of academic impact, for papers by Dorothy I. Shulman Breakdown of academic impact, for papers by Silvana Salardi Breakdown of academic impact, for papers by Neville J. Howard Breakdown of academic impact, for papers by J.M. Wit Breakdown of academic impact, for papers by Giorgio Radetti Breakdown of academic impact, for papers by Alessandro Salvatoni
Rankless by CCL
2026